Exploratory Pharmacodynamic Study of Tenofovir-Based Products
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This single site study is designed to describe and measure the efficacy of oral versus
vaginal dosing of TFV-based products, specifically emtricitabine/tenofovir disoproxil
fumarate oral tablets (Truvada) vs tenofovir intravaginal rings (IVR).
Phase:
Phase 1
Details
Lead Sponsor:
CONRAD
Collaborators:
Agility Clinical, Inc. Eastern Virginia Medical School University of North Carolina
Treatments:
Emtricitabine Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Tenofovir